Zhuhai Rundu Pharmaceutical Co Ltd Class A Cash Flow Conversion Efficiency

Latest as of September 2025: 0.036x

Zhuhai Rundu Pharmaceutical Co Ltd Class A cash flow conversion efficiency. Based on the latest financial reports, Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) has a cash flow conversion efficiency ratio of 0.036x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥37.78 Million ≈ $5.53 Million USD) by net assets (CN¥1.05 Billion ≈ $153.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Zhuhai Rundu Pharmaceutical Co Ltd Class A (2011–2025)

Cash flow conversion efficiency of Zhuhai Rundu Pharmaceutical Co Ltd Class A from 2011 to 2025. This chart illustrates how Zhuhai Rundu Pharmaceutical Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Zhuhai Rundu Pharmaceutical Co Ltd Class stock price today for real-time trading data and today's change.

Zhuhai Rundu Pharmaceutical Co Ltd Class A Cash Flow Conversion Ratio Explained

Zhuhai Rundu Pharmaceutical Co Ltd Class A cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Zhuhai Rundu Pharmaceutical Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhuhai Rundu Pharmaceutical Co Ltd Class A ranked by their cash flow conversion efficiency. Also see Zhuhai Rundu Pharmaceutical Co Ltd Class market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Kolte - Patil Developers Limited
NSE:KOLTEPATIL
0.136x
DONGGUAN R.COMMERC. H YC1
F:857
N/A
Deep Industries Limited
NSE:DEEPINDS
0.009x
Hangzhou Landscape Architecture Design Institute Co Ltd
SHE:300649
0.012x
Soft-World International
TWO:5478
0.116x
Vital Farms Inc
NASDAQ:VITL
-0.096x
Brainsway Ltd
NASDAQ:BWAY
0.080x
Magnera Corp placeholder
NYSE:MAGN
-0.013x

Annual Cash Flow Conversion Efficiency for Zhuhai Rundu Pharmaceutical Co Ltd Class A (2011–2025)

The table below shows the annual cash flow conversion efficiency of Zhuhai Rundu Pharmaceutical Co Ltd Class A from 2011 to 2025. Review 002923 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥1.04 Billion
≈ $151.95 Million
CN¥104.41 Million
≈ $15.28 Million
0.101x -45.15%
2024-12-31 CN¥1.15 Billion
≈ $168.59 Million
CN¥211.19 Million
≈ $30.90 Million
0.183x +25.17%
2023-12-31 CN¥1.18 Billion
≈ $172.55 Million
CN¥172.68 Million
≈ $25.27 Million
0.146x +29.73%
2022-12-31 CN¥1.20 Billion
≈ $175.01 Million
CN¥135.01 Million
≈ $19.76 Million
0.113x -39.03%
2021-12-31 CN¥1.11 Billion
≈ $162.74 Million
CN¥205.91 Million
≈ $30.13 Million
0.185x -23.22%
2020-12-31 CN¥1.04 Billion
≈ $151.93 Million
CN¥250.35 Million
≈ $36.63 Million
0.241x +49.86%
2019-12-31 CN¥940.29 Million
≈ $137.59 Million
CN¥151.30 Million
≈ $22.14 Million
0.161x -11.85%
2018-12-31 CN¥871.29 Million
≈ $127.50 Million
CN¥159.04 Million
≈ $23.27 Million
0.183x +53.97%
2017-12-31 CN¥488.84 Million
≈ $71.53 Million
CN¥57.95 Million
≈ $8.48 Million
0.119x -49.82%
2016-12-31 CN¥398.19 Million
≈ $58.27 Million
CN¥94.07 Million
≈ $13.77 Million
0.236x +46.41%
2015-12-31 CN¥310.72 Million
≈ $45.47 Million
CN¥50.14 Million
≈ $7.34 Million
0.161x -23.98%
2014-12-31 CN¥273.31 Million
≈ $39.99 Million
CN¥58.01 Million
≈ $8.49 Million
0.212x +58.34%
2013-12-31 CN¥236.29 Million
≈ $34.58 Million
CN¥31.67 Million
≈ $4.63 Million
0.134x -61.82%
2012-12-31 CN¥199.43 Million
≈ $29.18 Million
CN¥70.01 Million
≈ $10.25 Million
0.351x +72.18%
2011-12-31 CN¥165.33 Million
≈ $24.19 Million
CN¥33.71 Million
≈ $4.93 Million
0.204x --

About Zhuhai Rundu Pharmaceutical Co Ltd Class A

SHE:002923 China Drug Manufacturers - Specialty & Generic
Market Cap
$450.85 Million
CN¥3.08 Billion CNY
Market Cap Rank
#12506 Global
#3620 in China
Share Price
CN¥9.20
Change (1 day)
+1.10%
52-Week Range
CN¥8.81 - CN¥17.35
All Time High
CN¥20.52
About

Zhuhai Rundu Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations, APIs, and pharmaceutical intermediates in China and internationally. It offers FDF for cardiovascular, gastrointestinal, antibiotics, analgetic and antipyretics, anti-virus, endocrinology, and respiratory; and pellets for excipient, antiulcerative, diabetes … Read more